#savethejointTM

Regen Lab RegenKit®
A-PRP®

RegenKit® BCT produces A-PRP with an optimal cellular profile and platelet viability

RegenKit® A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single-use double blister.

RegenKit® cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.

Intended use of the device: Preparation of autologous platelet-rich plasma and other plasma-derived products.

A safe and effective leukocyte-reduced A_PRP 

The patient’s platelet concentrate prepared with RegenKit®

Platelets are key factors in hard and soft tissue repair mechanisms (1). They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally, platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively. The platelets are concentrated from the patient’s own blood.

Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.

  • The A-PRP prepared with the RegenBCT device has an excellent safety profile.
  • Red blood cells are removed at 99.7 %.
  • The white blood cell level is drastically reduced, with a preferential depletion (96.7 %) of the pro-inflammatory granulocytes.
  • The remaining white blood cells are mostly lymphocytes and monocytes.

RegenKit A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single or double blister.

RegenKit cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.

RegenKit BCT - Medical Device Class III - CE2797

 

Regen Lab RegenKit® A-PRP®

#savethejointTM


RegenKit® BCT produces A-PRP with an optimal cellular profile and platelet viability

RegenKit® A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single-use double blister.

RegenKit® cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.

Intended use of the device: Preparation of autologous platelet-rich plasma and other plasma-derived products.

A safe and effective leukocyte-reduced A_PRP 

 

RegenKit BCT - Medical Device Class III - CE2797

What is A-PRP ? Click here to find out more

The patient’s platelet concentrate prepared with RegenKit®

Platelets are key factors in hard and soft tissue repair mechanisms (1). They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Additionally, platelets also stimulate fibroblasts and endothelial cells to induce new extracellular matrix deposition and neo-vascularisation respectively. The platelets are concentrated from the patient’s own blood.

Plasma contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for the fibrin polymer formation will serve as a scaffold for cell migration and new tissue generation.

  • The A-PRP prepared with the RegenBCT device has an excellent safety profile.
  • Red blood cells are removed at 99.7 %.
  • The white blood cell level is drastically reduced, with a preferential depletion (96.7 %) of the pro-inflammatory granulocytes.
  • The remaining white blood cells are mostly lymphocytes and monocytes.

RegenKit A-PRP is composed of sterile disposable tubes, butterfly needle, transfer devices and syringes, packaged in a single or double blister.

RegenKit cell separator gel allows for the easy, rapid and consistent preparation, from a small volume of blood, of A-PRP with an optimal platelet concentration and viability.

FOR ANY PRODUCT INFORMATION YOU REQUIRE

More information


Company

JOINT OPERATIONS (UK) LLP
Unit 11 Interface Business Park
Bincknoll Lane
Royal Wootton Bassett
Wiltshire
SN4 8SY
UK

Company no. OC396027
VAT no. GB 198327955

Contact

OFFICE HOURS:

Mon - Fri 08:30 to 17:30
Tel. +44 (0) 1793 575 050

OUT OF HOURS BURNS SUPPORT:

Tel. +44 (0)1793 575 041

Joint Operations Helping innovators in their work...

© 2020 Joint Operations Ltd
website development .: Clockwork
Joint Operations is a ISO 9001:2005 registered company
Joint Operations is a ISO 9001:2005 registered company

Helping innovators in their work...

Joint Operations is a ISO 9001:2005 registered company
© 2020 Joint Operations Ltd
website development .: Clockwork